Nie, Qu <br/><br/>
Astragaloside IV protects against hyperglycemia-induced vascular endothelial dysfunction by inhibiting oxidative stress and Calpain-1 activation.  [electronic resource] 

 -  Life sciences  Sep 2019 
 - 116662 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0631 
<br/><br/><label>Standard No.: </label>10.1016/j.lfs.2019.116662  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcysteine--pharmacology<br/>Animals<br/>Aorta, Thoracic--drug effects<br/>Biomarkers--metabolism<br/>Calpain--metabolism<br/>Cysteine Proteinase Inhibitors--pharmacology<br/>Diabetes Mellitus, Experimental--metabolism<br/>Dipeptides--pharmacology<br/>Endothelium, Vascular--drug effects<br/>Human Umbilical Vein Endothelial Cells<br/>Humans<br/>Hyperglycemia--metabolism<br/>Male<br/>Nitric Oxide--metabolism<br/>Nitric Oxide Synthase Type III--metabolism<br/>Oxidative Stress--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Saponins--pharmacology<br/>Streptozocin<br/>Triterpenes--pharmacology<br/>Vasodilation--drug effects